Format

Send to

Choose Destination
Nitric Oxide. 2015 Nov 15;50:114-128. doi: 10.1016/j.niox.2015.08.007. Epub 2015 Aug 31.

Inhaled nitric oxide: Current clinical concepts.

Author information

1
Department of Medicine, University of Washington Medical Center, Seattle, WA, United States.
2
Division of Cardiothoracic Anesthesiology, Pediatric Cardiac Section, Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL, United States.
3
Division of Cardiothoracic Anesthesiology, Department of Anesthesiology and Pain Medicine, University of Washington Medical Center, Seattle, WA, United States.
4
Department of Anesthesiology and Pain Medicine, University of Washington Medical Center, 1959 NE Pacific St., Suite EE-201, Seattle, WA 98195-6540, United States. Electronic address: jdlang@uw.edu.

Abstract

Nitric oxide (NO) has come far since being discovered serendipitously to relax vascular smooth muscle. Initially, administered to animals to reduce pulmonary artery pressures and improve oxygenation. It now enjoys FDA approval for administration to newborns with pulmonary hypertension but is used common place for other critical cardiopulmonary ailments. While never quite living up to expectations, newer applications show greater promise as a therapy especially in the area of ischemia-reperfusion. The following will give a clinical overview of inhaled nitric oxide as a gas, as applied to the pediatric patient population, and to those adults suffering with cardiopulmonary and hematologic disease. Lastly, due to more recent discoveries, the effects of how NO may be used to treat disorders such as ischemia-reperfusion, will also be reviewed.

KEYWORDS:

ARDS; Inhaled nitric oxide; Injury; Ischemia; Lung injury; Nitric oxide; Nitrite; Pulmonary hypertension; Reperfusion; Transplantation

PMID:
26335378
DOI:
10.1016/j.niox.2015.08.007

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center